First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED
- Status
- COMPLETED
- Phase
- PHASE2
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
- Status
- RECRUITING
- Phase
- PHASE2